Topic: How To Invest

Pat: For more than a year, I have held Stellar Technologies as a speculative stock. It is now listed on Nasdaq, but hasn’t moved upward as expected. I would appreciate your opinion. Thank you.

Article Excerpt

Stellar Biotechnologies, $4.41, symbol KLH on Toronto (Shares outstanding: 8.4 million; Market cap: $47.7 million, www.stellarbiotechnologies.com), farms keyhole limpet hemocyanin (KLH). That’s a protein used in a range of therapeutic applications to stimulate the human immune system. Stellar’s KLH products can be used to create therapeutic vaccines, or immunotherapies. They are treatments that use the body’s own immune system to target and treat disease. KLH can also be used for immunodiagnostics. Those are tests that determine the health of a patient’s immune system before a new drug is used. KLH is refined from the “blood” of a rare clam-like snail—the giant keyhole limpet. That ocean dweller is found in the waters off Southern California and western Mexico. Its blood is called hemolymph and flows through its circulatory system. Using proprietary methods, Stellar farms KLH by raising snail embryos until they become protein-producing adults. Currently, the company’s competitors rely on scarce, wild populations of limpets. Stellar sells the KLH produced by its snails to…